Drugs / Carboprost methylate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05834361 | Jan → Dec 2022 | — | Peking Union Medical College Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Carboprost methylate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05834361 ↗ |
| Modality | Other / unclassified | “a PG-F2α analogue” NCT05834361 ↗ |